A drug which is said to "reboot" the immune system has been shown to be an effective treatment for multiple sclerosis (MS), a study has found.
The results of the trials were so encouraging in reducing the number of attacks in those affected that the MS Society is campaigning for the drug to become available on the NHS.
The research showed that alemtuzumab significantly reduced the number of attacks or relapses by people with MS compared to the current drug interferon beta-1a which is known commercially as Rebif.
More top news
Two bodies found in the Himalayas have been identified as Alex Lowe and David Bridges - 16 years after they went missing.
British troops have arrived in war-torn Somalia in a bid to tackle the threat from Islamists militants.
The first US cruise ship to Cuba for over 40 years has set sail from Miami.